This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Assessment after diagnosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Determining suitability for radical treatment of histologically-confirmed oesophageal or gastro-oesophageal junctional cancer after endoscopy and wholebody CT scan diagnosis

  • F-18 FDG PET-CT should be offered to people with oesophageal and gastro-oesophageal junctional tumours that are suitable for radical treatment (except for T1a tumours)

  • do not offer endoscopic ultrasound only to distinguish between T2-T3 tumours in people with oesophageal and gastro-oesophageal junctional tumours

  • endoscopic ultrasound should only be offered to people with oesophageal and gastrooesophageal junctional cancer when it will help guide ongoing management

  • staging laparoscopy should only considered for people with oesophageal or gastrooesophageal junctional cancer when it will help guide ongoing management.

HER2 testing in metastatic oesophago-gastric adenocarcinoma

  • HER2 testing should be offered to people with metastatic oesophago-gastric adenocarcinoma

Reference:

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.